Vanta Bioscience Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was INR 53.82 million compared to INR 52.76 million a year ago. Revenue was INR 54.04 million compared to INR 52.76 million a year ago. Net income was INR 0.197 million compared to INR 0.592 million a year ago. Basic earnings per share from continuing operations was INR 0.03 compared to INR 0.09 a year ago. Diluted earnings per share from continuing operations was INR 0.03 compared to INR 0.09 a year ago.